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doi:10.1016/j.ejvs.2011.05.013Abstract Objectives: To analyse the experience of a single centre and evaluate the early and
mid-term results of endovascular repair of complicated acute type B aortic dissection with
stentgrafts.
Method: From July 2002 to January 2009, 45 patients (12 women, 33 men) with complicated
acute type B aortic dissection (mean age, 42.6 years; range, 31e47 years) were treated with
Thoracic Endovascular Aortic Repair (TEVAR). Indications for treatment included rupture in
6(13%), hemathorax with impending rupture in 27(60%), malperfusion syndrome in 11 (22%),
and transient paraplegia in one patient (2.2%). Five kinds of commercially available thoracic
stentgrafts were used. Follow up was 100% during a period of 13 months (range, 1e36 months).
Results: Technical success (coverage of the primary tear site) was achieved in all 45
patients(100%) including deliberate partial or total coverage of the LSA in 7 patients (15.6%).
The 30-day and in-hospital mortality was 4.4% including one late rupture case. Overall survival
was 95.6% at 1 and 3-years’ follow-up. None of the patients with malperfusion required adjunct
distal stents All hemothoces resolved within 3months including 5 patient required thoracentesis
and one had tube thoracostomy. And 7 patients required temporary dialysis In-hospital compli-
cations occurred in 26.7% of patients and re-intervention was required in one patient and no
patient had postoperative paraplegia Postoperative CT angiography showed 25 patients
(58.1%) with complete thrombosis of the false lumen and re-expansion of the true lumen.
Conclusions: Endovascular repair of complicated acute type B aortic dissectionwith stentgraft is
proven to be a technically feasible and effective in this relatively difficult patient cohort, The
short and mid-term efficacy are persuasive, however, the long-term efficacy needs to be evalu-
ated further.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.3607444222; fax: þ86 731 85295832.
@yahoo.cn (C. Shu).
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Table 1 Patient demographics, comorbidities and indi-
cations for TEVAR.
Variable NO (%) or Mean
(range)
Age, mean  SD (range),y 42.6 (IQR: 31-47)
Male gender, No (%) 33(73.3%)
Uncontrolled Hypertension, No (%) 10(22.2%)
Diabetes, No (%) 8(17.8%)
Coronary artery disease, No (%) 6(13.3%)
COPD, No (%) 6(13.3%)
Chronic renal insufficiency, No (%) 7(15.6%)
Renal failure No (%) 7(15.6%)
Peripheral vascular disease, No (%) 8(17.8%)
Indications for TEVAR
Rupture 6(13%)
Haemothorax with impending rupture 27(60%)
Malperfusion
Celiac 1(2.2%)
Mensenteric 2(4.4%)
Renal 7(15.6%)
Lower extremity 1(2.2%)
Paraplegia 1(2.2%)
COPD Z chronic obstructive pulmonary disease.
Endovascular Repair of Complicated Acute Type-B Aortic Dissection with Stentgraft 449Acute type B aortic dissection (AD) is a dramatic and life-
threatening condition involving the thoracic aorta with
a high mobility and mortality.1,2 Although the advances in
surgical technique and the postoperative management have
been improved dramatically, surgical resection of the
descending aorta is still associated with high morbidity and
mortality.3 During the last decade, thoracic endovascular
aortic repair (TEVAR) of acute AD has gained increasing
attention as an initial treatment option. Although from
1999, TEVAR was introduced as a novel, less invasive
treatment and gained popularity in the treatment of
patients with type B AD,4,5 patients with complicated acute
type B ADs who present with life-threatening complica-
tions, including rupture or impending rupture, critical
malperfusion syndrome, intractable pain and uncontrolled
hypertension remain a challenging group to manage. Early
experience has demonstrated that TEVAR for complicated
acute type B dissection is associated with a better early
outcome and improved perioperative results relative to
conventional therapy.69 However, there is a need for
reassessment of this approach as it is continuously evolving.
The aim of this study was to report a single-centre expe-
rience with endovascular stentgraft repair of complicated
acute type-B AD and to evaluate its feasibility and
practicability.
Materials and Methods
Patients
From July 2002 to January 2009, 320 consecutive patients
were admitted to our centre, diagnosed with Stanford type B
AD. Of these 320 patients, 200 had acute type B ADs
(uncomplicated 155 and complicated 45). During the time
period of our study, no patient had open repair. In this group
of uncomplicated type B ADs, 130 patients (83.9%) were
treated with TEVAR, the remaining 25 patients (16.2%) were
treated with conservative medical therapies .All of these 45
patients (12 women and 33 men) with complicated acute
type B AD (mean age, 42.6 years; range, 31e47 years) were
treated with TEVAR. Indications for TEVAR included rupture
(six cases, 13%), haemothorax with impending rupture
(defined as an enlarged aortic diameter in the dissected
region with evidence of haemothorax and no active contrast
extravasations in the computed tomography (CT) imaging)
(27 cases, 60%), malperfusion syndrome (11 cases, severe
visceral ischemia: 3; lower extremity ischemia: 1; renal
failure, 7) and transient paraplegia in one patient (2.2%)
(Table 1). All the patient’s characteristics are described in
Table 1. All diagnoses were confirmed by computed tomog-
raphy angiography (CTA), magnetic resonance angiography
(MRA) or digital subtraction angiography (DSA). The endolu-
minal procedures were approved by the institutional review
board of our hospital and informed consent was obtained
from all patients and their relatives.
Procedure of stentgraft implantation
All patients were treated with commercially available sten-
tgrafts. The procedures were performed in the catheter-
isation suite under general anaesthesia. IVUS was not used inour series.A calibrated5Fpigtail catheterwas introduced into
the ascending aorta through the left subclavian artery (LSA)
for the localisation of the orifice of the LSA and intra-
procedural angiography. In some cases, the calibrated cath-
eter was introduced retrograde into the ascending aorta
directly through the femoral artery if the unilateral iliofe-
moral artery was uninvolvedwith the dissection. Angiography
was performed to confirm the primary entry tear and re-entry
sites and to determine the suitable size of the stentgraft. For
the patients with true lumen obliteration, which means the
true lumen was completely compressed by the false lumen,
we inserted the pigtail catheter and guidewire from the LSA,
downward to squeezeopen the true lumengraduallybymeans
ofhand-pull orhighpressure injection contrastmediumtillwe
arrived at the femoral artery, then the exchange guidewire
waspulledout of the femoral artery througharteriotomy.A 6F
pigtail catheter was introduced into the ascending aorta
through the femoral artery under fluoroscopic guidance with
frequent test injections to confirm its accuracy in the true
lumen. Besides that, we choose the following methods to
limiting the dye load especially for the patients with renal
dysfunction or failure1: preoperatively CTA to determine the
choice of peripheral access site and2 theposition of the pigtail
in the true lumen was confirmedwith a small dose of contrast
medium. A stentgraft with a larger diameter (usually10e20%)
was chosen to ensure secure anchoring and a tight circum-
ferential seal. Systolic blood pressure was titrated to
80e90 mmHg with sodium nitropresside before stentgraft
deployment to prevent displacement of the stentgraft during
delivery. Aortography was performed again to confirm the
following situation1: the closure of the primary entry tear2;
whether the LSA was covered by stent and3 whether an
endoleak existed.
Patients who presented with rupture or impending
rupture in our series were considered potential primary
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Figure 1 KaplaneMeier survival curve.
450 C. Shu et al.candidates for TEVAR. Preoperative CTA was used to
determine the size and type of aortic lesions, to assess the
potential landing zones as well as the scope of the rupture.
All patients required immediate volume resuscitation to
stabilise their haemodynamic condition before endovas-
cular procedure. Although coverage of the primary tear site
is equally essential for the patients with rupture or
impending rupture, the site of rupture must also be
covered, which means additional stentgrafts can even be
deployed immediately when perioperatively angiography
shows persistent endoleak on sites of distal tears after
primary site coverage. Besides that, considering the fatigue
condition of the aortic wall, post-dilation with a balloon
was not performed in these cases.
For the type B dissection complicated by the mal-
perfusion syndrome, the stentgraft was deployed to
expand the true lumen, obliterate the false lumen and
correct the malperfuison syndrome. Angiography was
performed again to assess the reestablishment of distal
perfusion after the stentgraft deployment. None of the
patients with malperfusion required adjunct distal stents
in our group.
Data collection and follow-up
The clinical data of preoperative comorbidities, indications
and postoperative condition of both admission and outpa-
tients were collected retrospectively. Follow-up data were
obtained by clinic visit and retrospective chart review. CTA
was conducted 2 weeks after operation and at least once
a year after discharge to evaluate the short and mid-term
efficacy and to monitor the thrombosis in the false lumen
and the enlargement of true lumen. Follow-up rate was
100% during mean period of 13 months (range, 1e36
months).
Statistical analysis
Statistical analysis was performed by using Statistical
Package for the Social Sciences (SPSS) software (SPSS. Inc,
Chicago, IL, USA); continuous variables were expressed as
the mean  standard deviation (SD). Survival was analysed
with KaplaneMeier survival curve.
Results
Technical success (coverage of the primary tear site) was
achieved in all 45 patients. The LSA was intentionally
partially (five cases) or totally (two cases) covered by the
stentgraft in seven patients. Mean fluoroscopy time and
contrast volume were 30  16 min and 176  55 ml,
respectively. The mean postoperative stay in the intensive
care unit (ICU) was 2.1  1.3 days (range 1e4) and the
mean hospital stay was 7.3  2.8 days (range 9e16).Five
different kinds of stentgrafts were used for the endovas-
cular treatment: Talent (Medtronic Inc, Minneapolis, MN,
USA) was used in four patients, Zenith (Cook Inc, Bloo-
mington, Ind, USA) in 13 patients, Ralay (Bolton Medical
Inc, Sunrise, Fla, USA) in three patients and Aegis (Micro-
port Life-sciences Co, Shanghai, China) in 25 patients. Fifty
stentgrafts were successfully deployed in 45 patients.Stentgrafts diameter ranged from 32 mm to 40 mm, and
median covered length of the descending aorta was 180 mm
(range, 150e230 mm).
Overall, two patients in the series died. The 30-day and
in-hospital mortality was 4.4% and the actuarial survival
was 95.6% at 1-year and 3-year intervals according to
KaplaneMeier analysis (Fig. 1). The first death occurred in
a patient who presented with acute complicated dissection
by rupture on postoperative day 10, the cause of death was
failure to recognise the distal tear site. One further death
occurred in hospital on postoperative day 35, this patient
died of visceral ischaemia and multi-organ dysfunction.
Haemothorax disappeared within 28 days to 3 months of
operation in all patients suffering from haemothorax. Most
cases of progressive increasing haemothorax were recov-
ered after stentgrafts deployment. However, thoracentesis
was required in five patients and tube thoracostomy was
required in an additional case to improve the respiratory
function.
Concerning the 11 patients with malperfusion, seven
presented with isolated acute renal failure and four cases
concomitant with either visceral or lower extremity
ischaemia. Five patients required transient haemodialysis
preoperatively because of acute renal failure. Two patients
required haemodialysis till their renal function recovered 7
days later even after the proximal primary entry tear had
been sealed. None of the malperfusion patients required
adjunct distal stents nor exploratory laparotomy after
TEVAR in our series. The gradual alleviation of visceral and
lower extremity ischaemia was recorded in four patients
1e14 days after TEVAR procedure. However, one mortality
occurred in a patient who had persistent late visceral
malperfusion because of lack of experience in the early
period. The paraplegia patient restored his myodynamia 4 h
after operation and returned to normal activity by means of
treatment including neurotrophic intravenous glucocorti-
coid therapy, as well as drainage of cerebrospinal fluid
(CSF).
No strokes and spinal cord ischaemia were documented
after TEVAR in our series, Neither postoperative paraplegia
nor conversion to open surgery occurred. Early post-
operative complications occurred in nine patients (20%,
Table 2) including three cases of pleural thickening, two
Table 2 Hospital morbidity and mortality.
Variable No (%) or Mean  SD
Mortality
30-day and in-hospital 2 (4.4%)
1-year survival, % 95.6%
Morbidity
Endoleak 3 (6.7%)
Stoke 0 (0%)
Transient paraplegia 0 (0%)
Visceral ischemia 2 (4.4%)
Pleural thickening 3 (6.7%)
Pulmonary atelectasis 2 (4.4%)
Lung consolidation 2 (4.4%)
Access failure 0 (0%)
Re-intervention 1 (2.2%)
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consolidation and two cases of ischaemia of the SMA and
renal artery.
Follow-up was 100% during a mean period of 13 months
(range, 1e36 months). One patient had an early type I
endoleak. The CTA showed partial covering of the orifice of
the LSA. There was residual flow into the false lumen from
the proximal entry tear. Therefore, re-intervention with
proximal extension of the stentgraft was required. Other
two patients had late type Ⅱ endoleak without any
presentation and are still being closely followed up.
Successful remodelling of the aorta was demonstrated by
CTA in 25 patients, with complete thrombosis of the false
lumen and re-expansion of the true lumen, 11 patients had
partial thrombosis of the false lumen and the remaining
seven patients continue to have some retrograde flow in
the false lumen through a re-entry tear distal to the sten-
tgraft, but these patients presented with no symptoms and
are still being closely followed up.Discussion
AD is a catastrophic clinical entity with high morbidity and
mortality rates. The International Registry of Acute Aortic
Dissection (IRAD) data indicates that complicated acute
type B dissection patients with malperfusion or impending
rupture undergoing open repair suffer a significant
morbidity and mortality.10 As the emergence of endovas-
cular stentgraft treatment has significantly altered the
indications for traditional open surgery of AD,11,12 TEVAR
has possibly emerged as the optimal choice for the
management of complicated acute type B AD.6e9 However,
given the absence of randomised controlled trials, there is
a need for continuous re-evaluation of the results.
Acute rupture is less common in type B AD than in type
A, but still occurs in up to 20% of patients during the course
of the disease and is the leading cause of death in acute AD.
In consideration of the high surgical morbidity and
mortality, TEVAR offers an effective therapeutic alterna-
tive for type B AD complicated by rupture with encouraging
results.1315 Our series includes six cases of acute type B
dissections with ruptures, five of whom survived aftersuccessful endovascular repair. We attribute the favourable
results to the careful and quick screening of the lesions’s
morphology and immediate volume resuscitation as well as
available appropriate-sized stentgraft. Although coverage
of the primary entry tear is equally essential, the site of
rupture must also be covered, which means there was an
effort to extend the additional stentgraft down to the distal
tears to cover the rupture area after primary site coverage.
However, one patient died of aortic rupture during the
follow up in our series thought to be failure to recognise the
distal tear site. That’s means further evaluation of this
technique is indicated to determine its effectiveness and
durability in the longer term.
It is well known that haemothorax is an unusual but well-
described complication of thoracic AD. In some cases,
pleural effusion or haemothorax, rather than chest or back
pain, is the first sign of AD.16 No special treatment is
needed for the small amounts of pleural effusion. However,
great care must be taken if there is a significant haemo-
thorax affecting respiratory function. In such cases, oxygen
therapy or even mechanical ventilator may be required
since impaired respiratory function resulting in hypoxemia
increases the mortality of acute AD. Emergency endovas-
cular repair is recommended for patients who suffer from
large haemothorax or progressive increasing pleural effu-
sion leading to respiratory dysfunction. Most cases of
progressive haemothorax in our study recovered after
stentgraft deployment, while respiratory functions were
improved by multiple thoracentesis aspirations or tube
thoracostomy for the patients with progressive increasing
haemathorax within 3e12 days after TEVAR. Our experi-
ence is to aspirate the haematocele or effusion under the
ultrasound guidance by 300e500 ml daily according to the
total amount of pleural effusion. Moderate aspiration is
recommended to maintain fundamental respiratory func-
tion rather than to eliminate all the haematocele from the
thoracic cavity which would break down the balance of
chest compressions and lead to catastrophic consequences.
Some clinical data show that acute mortality in type B
AD has been closely associated with ischaemic complica-
tions which occur in up to 30% of patients.17 Dynamic
obstruction of the branch vessel will lead to renal failure,
mesenteric infarction or lower extremity ischaemia. Our
experience is that emergency endovascular repair with
stentgraft to restoring blood flow of true lumen can
improve renal function, and prompt haemodialysis is
required for patients with renal dysfunction or failure.
Furthermore, strict control of the infusion and contrast
agent given perioperatively is also mandatory to compen-
sate for the impairment of renal function. For the patients
with mesenteric malperfusion or lower extremity malper-
fusion who demonstrated by abdominal pain or severe leg
ischaemia, no exploratory laparotomy nor adjunct distal
procedures were required after TEVAR in our early cases.
We think the depressurisation of false lumen will benefit
restoring blood flow of visceral and lower extremity
arteries. However, recently excellent results show that
deployment of an uncovered stent within the true lumen of
the obstructed artery was necessary especially for the
patients with persistent malperfusion or in vessels affected
by a static component.6,11,18 In the early period of our
study, we did not place any stents for those with
452 C. Shu et al.malperfusion because lack of experience, which lead to the
mortality occurred in a patient who had visceral ischaemia
and multi-organ dysfunction, but we still believe TEVAR in
the distal thoracic aorta with adjunct celiac, SMA or ilofe-
moral arteries bare metal stents should be considered to
correct the haemodynamic changes causing compression of
the true lumen.
Our experience of endovascular repair of complicated
acute type-B AD demonstrated favourable mortality rates,
without severe complications. No case of stroke was
documented in our study, neither postoperative paraplegia
nor conversion to open surgery occurred. The young age of
the patients in our group may explain in part good results,
and this is consistent with a recent study reported by Xiong
J and associates,19 which demonstrated the average age for
patients with type B dissection in China is 10 years younger
than that in the patients in a Western country, besides that,
less risk factors and comorbidities in our group have an
effect on the patient’s ability to tolerate the treatment and
consequently have a good outcome in aortic remodelling
after TEVAR, which suggests favourable rates of technical
success and improved short and mid-term survival.
However, the long-term results regarding the status of the
distal false lumen in aortic remodelling after TEVAR
remains unclear, although complete thrombosis of the false
lumen and re-expansion of the true lumen was achieved in
25 of 43 patients (58.1%). It is well known that increasing
the diameter of the patent false lumen has been demon-
strated to be a significant independent predictor of aortic
rupture and aneurysmal degeneration.20,21 Therefore, close
postoperative surveillance by imaging with CTA or MRA was
extremely important.
There are several limitations to the current study. First,
it is a retrospective non-randomised, observational single-
institution study. Besides, there is a lack of a risk-adjusted
control group undergoing open surgery or medical
management for similar aortic pathologies. In addition, to
make any significant conclusions regarding the durability of
TEVAR, it will be necessary to obtain longer term follow-up
information.Conclusion
This study demonstrated that endovascular repair of
complicated acute type-B AD with stentgraft proved to be
technically feasible and effective in this relatively difficult
patients cohort. Follow-up data indicate substantial dura-
bility of the treatment with an acceptable freedom from
stentgraft death and secondary interventions. Although the
results are promising, the occurrence of endoleaks, retro-
grade false lumen flow and possible need for re-
intervention procedures remain a cause for serious
concern. Long-term follow up is necessary to assess the
eventual outcomes. Until the results of randomised
controlled trials become available, the ultimate treatment
strategy will not be established.Conflict of Interest
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